Once-Daily Eye Drop for IOP Enters FDA Review - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Once-Daily Eye Drop for IOP Enters FDA Review

FDA acceptance puts Kowa Pharmaceuticals’ nitric oxide-donating bimatoprost on track for an April 2027 decision

  • September 15, 2026

  • 2 min

Share

Clinical Scorecard: Once-Daily Eye Drop for IOP Enters FDA Review

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Once-Daily Eye Drop for IOP Enters FDA Review
Key MechanismsNitric oxide-donating bimatoprost monotherapy designed to lower IOP.
Target PopulationPatients or participants described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • K-911 is a once-daily eye drop under FDA review for lowering IOP.
  • The drug is designed to enhance aqueous humor outflow.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of open-angle glaucoma or ocular hypertension.

Management

  • Lowering IOP is the primary goal.

Monitoring & Follow-up

  • Regular monitoring of IOP levels.

Risks

  • Treatment requirements may change over time.

Patient & Prescribing Data

Patients with open-angle glaucoma or ocular hypertension.

K-911 aims to provide a new treatment option for sustained IOP control.

Clinical Best Practices

    Related Resources & Content

    Original Source(s)

    Once-Daily Eye Drop for IOP Enters FDA Review

    • September 15, 2026

    Related Content

    Reflections on Lumenis Accelerate from Laura Periman, MD

    Optometric Management caught up with Laura Periman, MD, at the Lumenis Accelerate Owner’s Summit in Chicago on August 28 to discuss what attendees could take away from the event, both in clinical pearls and workflows and in practice management lessons.

    • September 1, 2026

    • 4 min
    Europe’s Cataract Benchmark

    EUREQUO data from more than 363,000 procedures show improving visual outcomes and low complication rates across Europe

    • September 15, 2026

    • 2 min
    Coastal Eye Associates Welcomes Dr. Sanchay Gupta

    Comprehensive ophthalmologist specializing in advanced cataract surgery joins Houston-area practice

    • September 7, 2026

    • 2 min